MenoGeniX
About:
MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.
Website: https://www.menogenix.com/
Top Investors: National Institutes of Health
Description:
MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in 2010 and is based in Aurora, Colorado.
Total Funding Amount:
$1.11M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Aurora, Colorado, United States
Founded Date:
2010-01-01
Contact Email:
info(AT)menogenix.com
Founders:
Debra M. Duke, Douglas Farrar
Number of Employees:
1-10
Last Funding Date:
2018-05-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai